Documente Academic
Documente Profesional
Documente Cultură
TROMBOEMBOLISMUL PULMONAR
ACUT CU RISC INALT
EPIDEMIOLOGIE
Incidenta TVP: 5 0/0000 in populatia generala -
creste cu varsta
Fowkes F.G. si colab. - European Journal of Vascular and Endovascular Surgery, 2003;25: 1-5
PATOGENIE
“Triada Virchow” si
particularitatile
trombozei venoase
profunde: importanta
factorilor de
coagulare plasmatica.
http://www.arjohuntleigh.net/hk/Page.asp?PageNumber=4621
PATOGENIE
HTP CRONICA
TROMBOEMBOLICA
Hull RD si colab. – Clin. Chest Med., 1984; 5: 439-456; Kearon C, Hirsch J – N. Engl. J. Med., 1997;
336: 15-6-1511; Helt JA si colab. – Arch. Intern. Med., 2000; 160: 761-68; Bernardi E. si colab. –
Semni. Vasc. Med., 2001; 1:71-79 - Stein P.D. si colab. – Am. J. Cardiol., 2004; 93: 1197-1199;
MANIFESTARI CLINICE DE EMBOLIE PULMONARA
- Gazometrie
- ECG – modificari specifice
- Rx cord-pulmon
- D-Dimeri – exclud MTEV de probabilitate clinica scazuta
daca sunt negativi (<500 ng/dL), Tn si NT-proBNP
http://www.aacc.org/publications/cln/archive/2009/april/Pages/series0409.aspx
ECG
http://hqmeded-ecg.blogspot.com/2018/03/a-crashing-patient-with-abnormal-ecg.html
ANGIO-CT
DIAGNOSTICUL ECOCARDIOGRAFIC
http://www.ajts.org/viewimage.asp?img=AsianJTransfusSci_2011_5_2_188_83266_f1.jpg
TRATAMENTUL EMBOLIEI PULMONARE
TRATAMENTUL EMBOLIEI PULMONARE
▪ Durata anticoagularii:
- 3 luni in TVP provocata
- 3-6 luni, dar preferabil nedefinit, in TVP
neprovocata
Kearon C si colab. – Antithrombotic therapy for VTE disease, Antithrombotic
Therapy and Prevention of Thrombosis, 9th ed.: American College of Chest
Physicions Evidence-Based Clinical Practice Guidelines, Chest, 2012; 141
(suppl.2): e419S – e494S
TRATAMENTUL TEP CU RISC
SCAZUT